<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="806">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04767087</url>
  </required_header>
  <id_info>
    <org_study_id>SZMC/IRB/Internal/273/2021</org_study_id>
    <nct_id>NCT04767087</nct_id>
  </id_info>
  <brief_title>Honey and Nigella Sativa in COVID-19 Prophylaxis</brief_title>
  <acronym>HNS-COVID-PK</acronym>
  <official_title>Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohaib Ashraf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheikh Zayed Federal Postgraduate Medical Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and&#xD;
      immunomodulatory roles. So it is planned to test for its prophylaxis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2021</start_date>
  <completion_date type="Anticipated">July 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SARS-CoV-2 infection rate</measure>
    <time_frame>14 days</time_frame>
    <description>RT-PCR SARS-CoV-2</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Honey and Nigella sativa Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.5 g/kg/day honey 40 mg/Kg/day Nigella sativa seeds</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>empty capsule with sugar water</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Honey</intervention_name>
    <description>0.5 gm/Kg/day honey</description>
    <arm_group_label>Honey and Nigella sativa Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nigella sativa seed</intervention_name>
    <description>40 mg/Kg/day</description>
    <arm_group_label>Honey and Nigella sativa Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>empty capsule with sugar water</description>
    <arm_group_label>Placebo Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Health care professionals Post-exposure COVID-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multi-organ failure active COVID-19&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sohaib Ashraf, MBBS</last_name>
    <role>Study Director</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Muhammad Ashraf, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Veterinary and Animal Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmad Imran, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shaikh Zayed Post-Graduate Medical Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moneeb Ashraf, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Edward Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sohaib Ashraf, MBBS</last_name>
    <phone>8573167995</phone>
    <email>sohaib@skzmdc.edu.pk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmad Imran, MBBS</last_name>
    <phone>+923338110708</phone>
    <email>ahmad.imran@skzmdc.edu.pk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shaikh Zayed Post-Graduate Medical Institute</name>
      <address>
        <city>Lahore</city>
        <state>MA</state>
        <zip>54600</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sohaib Ashraf, MBBS</last_name>
      <phone>03334474523</phone>
      <email>sohaib@skzmdc.edu.pk</email>
    </contact>
    <contact_backup>
      <last_name>Ahmad Imran, MBBS</last_name>
      <phone>+923338110708</phone>
      <email>ahmad.imran@skzmdc.edu.pk</email>
    </contact_backup>
    <investigator>
      <last_name>Iqra Farooq, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Larab Kalsoom, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shahroze Arshad, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maaz Akram, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Uzma N Siddique, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 20, 2021</study_first_submitted>
  <study_first_submitted_qc>February 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2021</study_first_posted>
  <last_update_submitted>February 20, 2021</last_update_submitted>
  <last_update_submitted_qc>February 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sheikh Zayed Federal Postgraduate Medical Institute</investigator_affiliation>
    <investigator_full_name>Sohaib Ashraf</investigator_full_name>
    <investigator_title>Registrar Cardiology</investigator_title>
  </responsible_party>
  <keyword>Honey</keyword>
  <keyword>Nigella sativa</keyword>
  <keyword>Prophylaxis</keyword>
  <keyword>COVID-19</keyword>
  <keyword>Prophetic Medicine</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

